Business - Briefly   

Foundation laid for Syngene's research facility

BANGALORE: Biocon's wholly owned subsidiary, Syngene International Private Limited, and global pharma major Bristol-Myers Squibb, conducted the ground breaking ceremony of their new research facility at Biocon Park, Bommasandra Industrial Area-Phase IV, here on Wednesday. Francis Cuss, Senior Vice-President, Pharmaceutical Research Institute, Bristol-Myers Squibb, laid the foundation. Kiran Mazumdar-Shaw, Chairman, Biocon group, and Goutam Das, Syngene's Chief Operating Officer, were present.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

PM calls for introspection on crisis in power sector
TRAI cuts Access Deficit Charge
IFC to invest $45m in Kotak Mahindra Bank
OBC, IDBI Capital sign pact
Tea gardens: Jairam writes to Buddhadeb
Avesthagen genetic database on Parsis
Quintegra buys software firms
Hanveev, Hantex revamp on cards
Syndicate Bank releases loans to farmers
Bhoomi puja for new hotel
IndusInd Bank's fifth ATM
Ernakulam achieves distinction in banking
Sensex up 240 points
Rupee gains further
Exchange rates
Bullion rates
Cabinet likely to take up FDI in telecom
Cement makers to meet FM today
SAIL to foray into cement manufacturing
Grain diversion blamed for higher food prices
CERC ropes in KPMG
Foundation laid for Syngene's research facility
Small and mid-cap fund from JM Financial
Dabur launches `Real Twist' fruit drink
`Intex' in Mumbai
CUB gets RBI nod for preferential issue
PNB opens rural branch with CBS
RSWM buys 48 p.c. stake in Cheslind Textiles

Copyright © 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu